A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients

NCT00956319 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders
Primary Insomnia

Interventions

DRUG: Zolpidem MR
DRUG: Estazolam

Sponsor

Astellas Pharma Inc